What is Illumina's cash & equivalents?

Illumina (ILMN) reported cash & equivalents of $1.09B in Q1 2026.

How has Illumina's cash & equivalents changed year-over-year?

Illumina's cash & equivalents decreased by 2.2% year-over-year, from $1.11B to $1.09B.

What is the long-term trend for Illumina's cash & equivalents?

Over 5 years (2020 to 2025), Illumina's cash & equivalents has grown at a -4.8% compound annual growth rate (CAGR), from $1.81B to $1.42B.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Illumina ILMN Cash & Equivalents

Cash & Equivalents at other companies

RevvityRVTY

$861.47M-24.3%

Thermo Fisher ScientificTMO

$3.28B-21.4%

AzentaAZTA

$125.19M—

Pacific Biosciences of CaliforniaPACB

$57.86M-4.7%

Personalis, Inc.PSNL

$73.59M+3.7%

Guardant HealthGH

$1.1B+37.0%

Other financials

Income statement

See full

Revenue$1.1B+4.8%

Gross profit$721.0M+5.6%

Operating income$209.0M+27.4%

Net income$134.0M+2.3%

EPS (diluted)$0.87+6.1%

Balance sheet

See full

Total debt$2.0B-3.0%

Total equity$2.7B+13.0%

Total assets$6.6B+6.1%

Cash flow

See full

Operating cash flow$289.0M+20.4%

CapEx$38.0M+18.8%

Free cash flow$251.0M+20.7%

Valuation

See full

Market cap$26.6B+91.5%

Enterprise value$27.56B+83.6%

P/E31.2×+20.1×

P/S6.1×+2.8×

Profitability

See full

Gross margin66.2%-0.1pp

Operating margin19.4%—

Net margin19.4%+12.7pp

FCF margin22.2%+2.0pp

Returns & leverage

See full

Return on equity33.8%+23.9pp

Debt / equity0.8×-0.1×

Current ratio1.7×-0.1×

Where this comes from

Reported directly by Illumina in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: Illumina’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Illumina's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Illumina's cash & equivalents?: Illumina (ILMN) reported cash & equivalents of $1.09B in Q1 2026.
How has Illumina's cash & equivalents changed year-over-year?: Illumina's cash & equivalents decreased by 2.2% year-over-year, from $1.11B to $1.09B.
What is the long-term trend for Illumina's cash & equivalents?: Over 5 years (2020 to 2025), Illumina's cash & equivalents has grown at a -4.8% compound annual growth rate (CAGR), from $1.81B to $1.42B.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.